Neurol. praxi. 2019;20(5):392-394 | DOI: 10.36290/neu.2019.146

Non malignant breakthrough pain treatment

MUDr. Marek Hakl, Ph.D.
Centrum léčby bolesti, Chirurgická klinika FN a LF MU, Brno

The non-oncology pain is often accompanied by acute pain worsening, whether the result of increased endeavor, stress or even weather changes. The optimal medicaments for treatment of these episodes are pharmaceuticals with fast release effect and relatively short effect. We could use drugs from non steroidal anti-inflammatory group, drug combination tramadol/paracetamol or on the Czech market new IR oxycodone. It exceed in fast effect, fierce effect and relatively few adverse effects. Case study describes woman of 58 years old with pain after two spine operations. Combined treatment of acute worsening of pain with tramadol/paracetamol was ineffective,on the contrary IR oxykodon 5mg was very effective.

Keywords: acute worsening of pain,rescue medication, IR oxykodon, side effects, tíme od onset

Published: November 1, 2019  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Hakl M. Non malignant breakthrough pain treatment. Neurol. praxi. 2019;20(5):392-394. doi: 10.36290/neu.2019.146.
Download citation

References

  1. Dickman A. Integrated strategies for the successful management of breakthrough cancer pain. Curr Opin Support Palliat Care. 2011; 5: 8-14. Go to original source... Go to PubMed...
  2. https://www.drugs.com/professionals.html.
  3. http://www.sukl.cz/modules/medication/detail.php?code=0194640&tab=texts.
  4. Kabelka L, Kozák J, Lejčko J, Sláma O. Doporučený postup pro léčbu průlomové bolesti. Bolest 2011; 14(suppl. 1).
  5. Matodické pokyny pro farmakoterapii bolesti. Bolest 2016; (suppl. 1).
  6. Sunshine A, Olson NZ, Colon A, Rivera J, Kaiko RF, Fitzmartin RD, Reder RF, Goldenheim PD. Analgesic efficacy of controlled-release oxycodone in postoperative pain. J Clin Pharmacol. 1996; 36(7): 595-603. Go to original source... Go to PubMed...




Neurology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.